Industry News
Fewer, larger radiotherapy doses prove effective for prostate cancer patients
9/28/2015
Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research* presented at the 2015 European...
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the...
Scientists use microchip approach to visualize human breast cancer proteins
9/28/2015
A photograph may reveal how something looks, but direct observation can divulge how the objects behave. The difference can mean life or death, especially when it comes to fighting human disease.
Fewer, larger radiotherapy doses prove effective for prostate cancer patients
9/28/2015
Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research* presented at the 2015 European...
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the...
Social deprivation and gender affects incidence of Hodgkin lymphoma in children and young adults
9/28/2015
Living in overcrowded conditions appears to protect children and young adults against developing a particular type of Hodgkin lymphoma (HL), a cancer that originates from the lymphocytes (white...
A novel computer-aided detection (CAD) scheme based on a hybrid multi-classifier method could enhance early detection of lung nodules on CT images and help in the earlier diagnosis of lung cancer...
The International Kidney Cancer Coalition (IKCC) has announced the launch of a new internet platform "10-for-IO" - Ten for immuno-oncology (IO) - offering comprehensive information about...
Post diagnosis aspirin improves survival in all gastrointestinal cancers
9/28/2015
Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show.
Study finds drug improves survival for patients with non-small cell lung cancer
9/28/2015
A new phase 3 trial finds that overall survival is longer for patient with non-small cell lung cancer treated with the drug nivolumab compared with chemotherapy drug docetaxel.